• Tilray Brands Inc TLRY.OQ reported a quarterly adjusted loss of 10 cents​​ per share for the quarter ended November 30, lower than the same quarter last year, when the company reported breakeven earnings per share. The mean expectation of eight analysts for the quarter was for a loss of 4 cents per share. Wall Street expected results to range from -5 cents to -3 cents per share.

• Revenue rose 8.9% to $210.95 million from a year ago; analysts expected $216.91 million.

• Tilray Brands Inc's reported EPS for the quarter was a loss of 10 cents​.

• The company reported a quarterly loss of $85.28 million.

• Tilray Brands Inc shares had risen by 3.0% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 9.1% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy," 10 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the pharmaceuticals peer group is also "hold"

Wall Street's median 12-month price target for Tilray Brands Inc is $2.00

This summary was machine generated from LSEG data January 10 at 02:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)